{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:47:16Z","timestamp":1787500036428,"version":"build-2736575974"},"reference-count":46,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2015,7,22]]},"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurofibromatosis 2 (NF2) is an autosomal-dominant tumour predisposition syndrome characterised by bilateral vestibular schwannomas, considerable morbidity and reduced life expectancy. Although genotype\u2013phenotype correlations are well established in NF2, little is known about effects of mutation type or location within the gene on mortality. Improvements in NF2 diagnosis and management have occurred, but their effect on patient survival is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated clinical and molecular predictors of mortality in 1192 patients (771 with known causal mutations) identified through the UK National NF2 Registry. Kaplan\u2013Meier survival and Cox regression analyses were used to evaluate predictors of mortality, with jackknife adjustment of parameter SEs to account for the strong intrafamilial phenotypic correlations that occur in NF2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 241 deaths during 10\u2005995 patient-years of follow-up since diagnosis. Early age at diagnosis and the presence of intracranial meningiomas were associated with increased mortality, and having a mosaic, rather than non-mosaic,\n                      <jats:italic>NF2<\/jats:italic>\n                      mutation was associated with reduced mortality. Patients with splice-site or missense mutations had lower mortality than patients with truncating mutations (OR 0.459, 95% CI 0.213 to 0.990, and OR 0.196, 95% CI 0.213 to 0.990, respectively). Patients with splice-site mutations in exons 6\u201315 had lower mortality than patients with splice-site mutations in exons 1\u20135 (OR 0.333, 95% CI 0.129 to 0.858). The mortality of patients with NF2 diagnosed in more recent decades was lower than that of patients diagnosed earlier.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Continuing advances in molecular diagnosis, imaging and treatment of NF2-associated tumours offer hope for even better survival in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmedgenet-2015-103290","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T01:59:32Z","timestamp":1442973572000},"page":"699-705","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":99,"title":["Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients"],"prefix":"10.1136","volume":"52","author":[{"given":"Adam","family":"Hexter","sequence":"first","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, St Mary's Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Joe","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heap","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, St Mary's Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam J","family":"Smith","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Wallace","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, St Mary's Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Halliday","sequence":"additional","affiliation":[{"name":"Medical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Parry","sequence":"additional","affiliation":[{"name":"Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Taylor","sequence":"additional","affiliation":[{"name":"Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Raymond","sequence":"additional","affiliation":[{"name":"Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Guy's and St. Thomas\u2019 Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Afridi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guy's and St. Thomas\u2019 Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Obholzer","sequence":"additional","affiliation":[{"name":"Department of Ear, Nose and Throat, Guy's and St. Thomas\u2019 Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Axon","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T","family":"King","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Salford Royal NHS Foundation Trust, St. Mary's Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The English Specialist NF2 Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M","family":"Friedman","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, Canada"},{"name":"Child & Family Research Institute, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Gareth R","family":"Evans","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, St Mary's Hospital, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"2025100511105057000_52.10.699.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33139"},{"key":"2025100511105057000_52.10.699.2","unstructured":"Evans DG . Neurofibromatosis 2. In: Pagon RA , Adam MP , Ardinger HH , et al . eds. GeneReviews\u00ae . Seattle, WA: University of Washington, Seattle, 1993\u20132015. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1201\/"},{"key":"2025100511105057000_52.10.699.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.04.001"},{"key":"2025100511105057000_52.10.699.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1195-2"},{"key":"2025100511105057000_52.10.699.5","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q J Med"},{"key":"2025100511105057000_52.10.699.6","doi-asserted-by":"publisher","DOI":"10.1017\/S002221510012328X"},{"key":"2025100511105057000_52.10.699.7","first-page":"69","article-title":"A mutation in the Neurofibromatosis type 2 tumour suppressor gene giving rise to widely different clinical phenotypes in two unrelated individuals","volume":"55","author":"Bourn","year":"1994","journal-title":"Am J Hum Genet"},{"key":"2025100511105057000_52.10.699.8","doi-asserted-by":"publisher","DOI":"10.1086\/342716"},{"key":"2025100511105057000_52.10.699.9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.3.335"},{"key":"2025100511105057000_52.10.699.10","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050255"},{"key":"2025100511105057000_52.10.699.11","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease","volume":"59","author":"Ruttledge","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2025100511105057000_52.10.699.12","first-page":"529","article-title":"Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities","volume":"59","author":"Parry","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2025100511105057000_52.10.699.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01315.x"},{"key":"2025100511105057000_52.10.699.14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/3.5.813","article-title":"Germline mutations in the neurofibromatosis type 2 tumour suppressor gene","volume":"5","author":"Bourn","year":"1994","journal-title":"Hum Molec Genet"},{"key":"2025100511105057000_52.10.699.15","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.6.450"},{"key":"2025100511105057000_52.10.699.16","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.6.701"},{"key":"2025100511105057000_52.10.699.17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.029504"},{"key":"2025100511105057000_52.10.699.18","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000035638.74084.F4"},{"key":"2025100511105057000_52.10.699.19","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.047753"},{"key":"2025100511105057000_52.10.699.20","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.10181"},{"key":"2025100511105057000_52.10.699.21","unstructured":"Mosteller F , Tukey JW . Data analysis and regression: a second course in statistics. Reading, MA: Addison-Wesley, 1977."},{"key":"2025100511105057000_52.10.699.22","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318211faa9"},{"key":"2025100511105057000_52.10.699.23","first-page":"1","article-title":"Causes of mortality in neurofibromatosis type 2","volume":"25","author":"Aboukais","year":"2014","journal-title":"Br J Neurosurg"},{"key":"2025100511105057000_52.10.699.24","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.99.3.0480"},{"key":"2025100511105057000_52.10.699.25","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.96.2.0217"},{"key":"2025100511105057000_52.10.699.26","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.96.2.0223"},{"key":"2025100511105057000_52.10.699.27","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200409000-00027"},{"key":"2025100511105057000_52.10.699.28","doi-asserted-by":"publisher","DOI":"10.3171\/2012.3.JNS111649"},{"key":"2025100511105057000_52.10.699.29","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320520411"},{"key":"2025100511105057000_52.10.699.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.12.042"},{"key":"2025100511105057000_52.10.699.31","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.7.542"},{"key":"2025100511105057000_52.10.699.32","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.6.459"},{"key":"2025100511105057000_52.10.699.33","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.070342"},{"key":"2025100511105057000_52.10.699.34","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050191"},{"key":"2025100511105057000_52.10.699.35","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980518)77:3<228::AID-AJMG8>3.0.CO;2-L"},{"key":"2025100511105057000_52.10.699.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2012.01525.x"},{"key":"2025100511105057000_52.10.699.37","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2001.6672"},{"key":"2025100511105057000_52.10.699.38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1242\/jcs.112.6.895","article-title":"Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin","volume":"112","author":"Gr\u00f6nholm","year":"1999","journal-title":"J Cell Sci"},{"key":"2025100511105057000_52.10.699.39","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D"},{"key":"2025100511105057000_52.10.699.40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207142"},{"key":"2025100511105057000_52.10.699.41","doi-asserted-by":"publisher","DOI":"10.1593\/neo.11356"},{"key":"2025100511105057000_52.10.699.42","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2010.085241"},{"key":"2025100511105057000_52.10.699.43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/gcc.20733","article-title":"Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes","volume":"49","author":"Abo-Dalo","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"2025100511105057000_52.10.699.44","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1281-3"},{"key":"2025100511105057000_52.10.699.45","doi-asserted-by":"publisher","DOI":"10.1080\/02688690500081206"},{"key":"2025100511105057000_52.10.699.46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3011"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2015-103290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:10:58Z","timestamp":1759687858000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2015-103290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,9,22]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1136\/jmedgenet-2015-103290"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2015-103290","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}